期刊文献+

RP-HPLC-ELSD法测定康柏西普眼用注射液中辅料吐温20的含量 被引量:7

Determination of Tween 20 in conbercept ophthalmic injection by RP- HPLC- ELSD
原文传递
导出
摘要 目的: 建立反相高效液相色谱法联用蒸发光散射检测器测定康柏西普眼用注射液中辅料吐温20含量的分析方法。 方法: 采用Agilent Poroshell 120 SB-C18(2.7 μm,4.6 mm×150 mm)色谱柱,以乙腈-纯水为流动相进行梯度洗脱(0-5 min,5%B;5-6 min,5%B→60%B;6-10 min,60%B→80%B;10-15 min,80%B;15-15.01 min,80%B→5%B;15.01-20 min,5%B),流速0.5 mL·min^-1,蒸发光散射检测器漂移管温度为45 ℃,雾化压力设为2.8×10^5 Pa。 结果: 吐温20进样量在1.12-6.72 μg范围内,与色谱峰面积呈良好线性关系(R^2〉0.999);高、中、低浓度样品的回收率均在100%±10%范围内。 结论: 本法经方法学验证可用于康柏西普眼用注射液中辅料吐温20含量的检测。 Objective: To develop an RP-HPLC-ELSD method for the determination of Tween 20 in Conbercept ophthalmic injection. Methods: The analysis was carried out on the Agilent Poroshell 120 SB-C18(2.7 μm,4.6 mm× 150 mm)column.The mobile phase was composed of acetonitrile and water in gradient elution(0-5 min,5%B;5-6 min,5%B→60%B;6-10 min,60%B→80%B; 10-15 min,80%B;15-15.01 min,80%B→5%B;15.01- 20 min,5%B).And the flow rate was 0.5 mL·min^-1.The ELSD was maintained at 45 ℃ throughout the determination,and the nebulizer(nitrogen)gas pressure was set at 2.8×10^5 Pa. Results: The linear ranges of Tween 20 were 1.12-6.72 ug,and the sample size had a good linear relationship with the chromatographic peak area(R^2〉0.999).The recoveries were all in the range of 100%±10% at high,medium and low concentrations. Conclusion: The methodology validation showed that the method can be used for determination of Tween 20 in Conbercept ophthalmic injection.
出处 《药物分析杂志》 CAS CSCD 北大核心 2014年第6期1073-1076,共4页 Chinese Journal of Pharmaceutical Analysis
基金 四川省重大产业技术创新专项"国家一类新药--新型抗体类抗眼底新生血管生成药物KH902的产业化工艺及临床研究"(2011CD00071)
关键词 康柏西普眼用注射液 聚山梨酯20 吐温20 非离子表面活性剂 药用辅料检测 反相高效液相色谱法 蒸发光散射检测 conbercept ophthalmic injection polysorbate 20 Tween 20 nonionic surfactant pharmaceutic adjuvant determination RP - HPLC ELSD
  • 相关文献

参考文献13

二级参考文献44

共引文献146

同被引文献71

  • 1崔志伟,杨黎明,高琼.聚山梨酯80含量测定方法的改进验证[J].科技资讯,2006,4(12):186-186. 被引量:1
  • 2吕秋军.生物技术药物免疫原性的评价及面临的挑战[J].中国新药杂志,2007,16(3):181-188. 被引量:24
  • 3辛中帅,梁成罡,李克坚,杨化新.荧光光度法测定重组人生长激素注射液中聚山梨醇酯20的含量[J].药物分析杂志,2007,27(12):1887-1890. 被引量:6
  • 4Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells[J]. Biochem Biophys Res Commun, 1989(161):851-858.
  • 5Aiello LP, Northrup JM, Keyt BA, et al. Hypoxic regulation of vascular endothelial growth factor in retinal cells[J]. Arch Ophthalmol, 1995(113): 1538-1544.
  • 6Noma H, Funatsu H, Minura T, et al. Role of soluble vascular endothelial growth factor receptor-2 in macular edema with central retinal vein occlusion[J~. Br J Ophthal~ol, 201 l, 95(6)" 78g-792.
  • 7Noma H, Funatsu H, Minura T, et al. Vascular endothelial growth factor receptor-2 in macular edema with retinal vein occlusion[J]. Ophthalmic Res, 2012, 48(1):56-58.
  • 8Kvanta A, Algvere PV, Berglin L, et al. Subfoveal fibrovascular membranes in age related macular degeneration express vascular endothelial growth factor[J]. Invest OphthalmolVisSci, 1996(37): 1929-1934.
  • 9Ferrara N. Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy[J]. Nat Med, 2010, 16(10): 1107-11ll.
  • 10Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration [J]. N Engl J Med, 2004, 351(27): 2805-2816.

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部